Evidence map›Paper›PMID 33447320›Full record

ArticleCardiology research2021

Association Between the Level of Low-Density Lipoprotein Cholesterol and Coronary Atherosclerosis in Patients Who Have Undergone Coronary Computed Tomography Angiography.

Hiroko Inoue, Yuhei Shiga, Kohei Tashiro, Yuto Kawahira, Yasunori Suematsu, Yoshiaki Idemoto, Kanako Tano, Takashi Kuwano, Makoto Sugihara, Hiroaki Nishikawa and 2 more

Open access · diamondAbstract read
In one paragraph

Article in Cardiology research, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 4 papers.

0numbers the graph read from it
0cells of the map it votes in
4citing papers in PubMed
0.4field-weighted citation impact, top 34% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

4 citing papers in PubMed, 5 citations in OpenAlex.

  1. Article
  2. Article
  3. The site-specific distribution of atheromatous plaques in the coronary arteries.Postepy w kardiologii interwencyjnej = Advances in interventional cardiology · 2023
    Review
  4. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

12 authors at 1 institution in 1 country.

Hiroko InoueDepartment of Cardiology, Fukuoka University Nishijin Hospital, Fukuoka, Japan.
Yuhei ShigaDepartment of Cardiology, Fukuoka University School of Medicine, Fukuoka, Japan.
Kohei TashiroDepartment of Cardiology, Fukuoka University School of Medicine, Fukuoka, Japan.
Yuto KawahiraDepartment of Cardiology, Fukuoka University School of Medicine, Fukuoka, Japan.
Yasunori SuematsuDepartment of Cardiology, Fukuoka University School of Medicine, Fukuoka, Japan.
Yoshiaki IdemotoDepartment of Cardiology, Fukuoka University School of Medicine, Fukuoka, Japan.
Kanako TanoDepartment of Cardiology, Fukuoka University School of Medicine, Fukuoka, Japan.
Takashi KuwanoDepartment of Cardiology, Fukuoka University School of Medicine, Fukuoka, Japan.
Makoto SugiharaDepartment of Cardiology, Fukuoka University School of Medicine, Fukuoka, Japan.
Hiroaki NishikawaDepartment of Cardiology, Fukuoka University Nishijin Hospital, Fukuoka, Japan.
Yousuke KatsudaDepartment of Cardiology, Fukuoka University Nishijin Hospital, Fukuoka, Japan.
Shin-Ichiro MiuraDepartment of Cardiology, Fukuoka University Nishijin Hospital, Fukuoka, Japan.
Fukuoka University · JP

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundAlthough the Japan Atherosclerosis Society Guidelines 2017 recommend lower levels of low-density lipoprotein cholesterol (LDL-C, < 70 mg/dL or ≤ 100 mg/dL) to prevent secondary cardiovascular events, we cannot conclude that a low level of LDL-C prevents primary cardiovascular events in patients with suspected coronary artery disease (CAD).

methodsWe registered 1,016 patients who were clinically suspected to have CAD and who underwent coronary computed tomography angiography (CCTA) for screening of coronary atherosclerosis. We excluded 350 patients who were receiving anti-lipidemic therapies and finally analyzed 666 patients. The patients were divided into three groups according to the LDL-C level: < 70 mg/dL (n = 25, Low LDL-C), 70 - 99 mg/dL (n = 141, Middle LDL-C), and ≥ 100 mg/dL (n = 500, High LDL-C). A ≥ 50% coronary stenosis was initially diagnosed as CAD, and the number of significantly stenosed coronary vessels (VD), Gensini score and coronary artery calcification (CAC) score were quantified.

resultsThere were no significant differences in age, high-density lipoprotein cholesterol, rates of hypertension, hemoglobin A1c, blood sugar or systolic blood pressure among the Low, Middle and High LDL-C groups. On the other hand, there were significant differences in rates of males, smoking, dyslipidemia and diabetes, diastolic blood pressure and triglyceride among the groups. The prevalence of CAD values in the Low, Middle and High LDL-C groups were similar, at 52%, 47%, and 46%, respectively. In addition, there were no significant differences in the number of VD, Gensini score or CAC score among the Low LDL-C, Middle LDL-C and High LDL-C groups.

conclusionsWe showed that the level of LDL-C was not associated with the presence or severity of CAD, which indicates that we need to screen by CCTA to prevent primary coronary events even if patients without anti-lipidemic therapies show low levels of LDL-C.

Indexed as

Coronary artery diseaseCoronary computed tomography angiographyGensini scoreLow-density lipoprotein cholesterol

Identifiers

PMID33447320
PMCPMC7781266
OpenAlexW3112952992

What Socratic holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.